Necitumumab (Portrazza) is contraindicated for which type of cancer due to increased mortality and toxicity?

Correct answer: Non-squamous NSCLC

Explanation

This question assesses the ability to identify the specific cancer type for which necitumumab is contraindicated, as opposed to indicated.

Other questions

Question 1

What is the therapeutic classification for crisaborole (Eucrisa)?

Question 2

For which patient population is the safety of crisaborole (Eucrisa) not established, according to the 'Use Cautiously in' section?

Question 3

What is the intravenous dosage of daratumumab (Darzalex) from Week 9 to Week 24 when used as monotherapy?

Question 4

Which of the following is listed as a life-threatening hematologic adverse reaction for daratumumab?

Question 5

Delafloxacin (Baxdela) is contraindicated in patients with a history of which condition?

Question 6

What is the recommended oral dosage of delafloxacin (Baxdela) for adults with acute bacterial skin infections?

Question 7

For a patient with an eGFR of 20 mL/min, what is the adjusted IV dose of delafloxacin (Baxdela)?

Question 8

Elotuzumab (Empliciti) is indicated for patients with multiple myeloma who have received how many prior therapies?

Question 9

What is the pharmacologic classification for the drug combination emtricitabine/rilpivirine/tenofovir alafenamide (Odefsey)?

Question 10

Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide) is contraindicated for concurrent use with which herbal supplement?

Question 11

For which indication is Odefsey prescribed in treatment-naive patients?

Question 12

What is the therapeutic classification of etecalcitide (Parsabiv)?

Question 13

Etecalcitide (Parsabiv) is contraindicated in patients with which condition?

Question 14

What is the initial intravenous dosage for etecalcitide (Parsabiv)?

Question 15

Lesinurad (Zurampic) is contraindicated for concurrent use with which type of medication?

Question 16

What is the recommended oral dosage of lesinurad (Zurampic) for adults?

Question 17

Mepolizumab (Nucala) is indicated as an add-on maintenance treatment for what condition?

Question 18

What is the subcutaneous dosage of mepolizumab (Nucala) for adults and children 12 years and older?

Question 20

What is the intravenous dosage for necitumumab (Portrazza)?

Question 21

What is the therapeutic classification for reslizumab (Cinqair)?

Question 22

Which of the following is a listed adverse reaction for reslizumab (Cinqair)?

Question 23

What is the adult intravenous dosage for reslizumab (Cinqair)?

Question 24

Selexipag (Uptravi) is contraindicated for concurrent use with inhibitors of which enzyme?

Question 25

What is the adjusted daily dose of selexipag (Uptravi) for adults with moderate hepatic impairment (Child-Pugh Class B)?

Question 26

Sofosbuvir/velpatasvir/voxilaprevir (Vosevi) is indicated for chronic hepatitis C virus (HCV) of which genotypes?

Question 27

What is the adult dosage for sofosbuvir/velpatasvir/voxilaprevir (Vosevi)?

Question 28

Sonidegib (Odomzo) is indicated for the treatment of which condition?

Question 29

What is a listed musculoskeletal (MS) adverse reaction for sonidegib (Odomzo)?

Question 30

What is the therapeutic classification for sugammadex (Bridion)?

Question 31

Sugammadex is contraindicated in patients with severe renal impairment, defined as a creatinine clearance (CCr) less than what value?

Question 32

For routine reversal of a moderate neuromuscular blockade induced by rocuronium, what is the single IV dose of sugammadex for adults?

Question 33

What new dosage form is listed for the drug amphetamine?

Question 34

What is the new dosage form listed for buprenorphine (Probuphine)?

Question 35

The drug lisdexamfetamine (Vyvanse) is now available in which new dosage form?

Question 36

Which new dosage form is listed for the drug naloxone (Narcan)?

Question 37

What is the new dosage form for sumatriptan (Onzetra Xsail)?

Question 38

According to the 'DISCONTINUED DRUGS' table, which of these drugs has been discontinued by its manufacturer?

Question 39

What reason is provided in the appendix for the discontinuation of ezogabine (Potiga)?

Question 40

Which of the following discontinued drugs is also known by the brand name Doribax?

Question 41

A key adverse reaction for elotuzumab (Empliciti) is hepatotoxicity. What is another listed gastrointestinal (GI) side effect?

Question 42

What is the dosage of elotuzumab (Empliciti) for the first two cycles of treatment (Weeks 1-4)?

Question 43

For which age group is Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide) indicated at a dosage of 1 tablet once daily?

Question 44

Which serious dermatologic adverse reaction is listed for Odefsey?

Question 45

What is a listed cardiovascular (CV) adverse reaction for etecalcitide (Parsabiv)?

Question 46

Lesinurad should not be used with allopurinol doses at or above 300 mg/day under what condition?

Question 47

What is the new dosage form of hydrocodone bitartrate (Vantrela ER)?

Question 48

The drug sulfamethoxazole is listed in the appendix as being discontinued for what reason?

Question 49

Which drug is listed in the appendix as a phosphodiesterase type 4 inhibitor?

Question 50

What new dosage form is listed for morphine sulfate (Arymo ER)?